Breaking into the U.S. Market: Are Accelerators Worth It?

This article explores the insights of Karina Sotnik, founder and CEO of WorldUpstart, on what it takes for international healthcare startups to successfully expand into the US market. Sotnik outlines the key challenges global companies face — from navigating FDA clearance and reimbursement strategy to understanding US fundraising expectations and operational complexity. She emphasizes that US market entry requires early, integrated planning, where regulatory, IP, reimbursement, and fundraising decisions must be treated as interconnected rather than separate. Sotnik also addresses common misconceptions, including the difference between running pilots and achieving real traction, and why FDA clearance alone does not guarantee commercial success.

Read the full interview on R2GConnect.